Nanobiotix SA (XPAR:NANO)
€ 4.86 -0.122 (-2.45%) Market Cap: 230.39 Mil Enterprise Value: 205.67 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 29/100

Q4 2022 Nanobiotix SA Earnings Call Transcript

Apr 25, 2023 / 12:00PM GMT
Release Date Price: €2.4 (-31.47%)
Operator

Good day, and thank you for standing by. Welcome to the Nanobiotix business update and full-year 2022 financial results conference call.

A slide presentation accompanying this call can be found at the Investors section of the company's website at www.nanobiotix.com. (Operator Instructions) Please be advised that today's conference is being recorded.

At this point, I will turn the call over to Craig West, Senior Vice President of Investor Relations of Nanobiotix.

Craig West
Nanobiotix S.A. - SVP, IR

Thank you, operator. Good afternoon, and good morning. And welcome to the Nanobiotix conference call to discuss our full-year 2022 financial and operating results. Joining me on the call today are Laurent Levy, Co-Founder and Chief Executive Officer; and Bart Van Rhijn, Chief Financial Officer.

As a reminder, today's call is being webcast and will be available on our website for replay. I would like to remind you that this call will include forward-looking statements,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot